| pubmed-article:6613585 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6613585 | lifeskim:mentions | umls-concept:C0005695 | lld:lifeskim |
| pubmed-article:6613585 | lifeskim:mentions | umls-concept:C0042027 | lld:lifeskim |
| pubmed-article:6613585 | lifeskim:mentions | umls-concept:C0227666 | lld:lifeskim |
| pubmed-article:6613585 | lifeskim:mentions | umls-concept:C0031364 | lld:lifeskim |
| pubmed-article:6613585 | lifeskim:mentions | umls-concept:C0549099 | lld:lifeskim |
| pubmed-article:6613585 | lifeskim:mentions | umls-concept:C0596263 | lld:lifeskim |
| pubmed-article:6613585 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:6613585 | lifeskim:mentions | umls-concept:C0443254 | lld:lifeskim |
| pubmed-article:6613585 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:6613585 | pubmed:dateCreated | 1983-10-28 | lld:pubmed |
| pubmed-article:6613585 | pubmed:abstractText | The influence of 0.535% phenacetin in the diet or mechanical perforation of the renal pelvis and urinary bladder of male Sprague-Dawley rats in FANFT-induced urinary tract carcinogenesis was studied. The 151 rats were divided into 5 experimental and one control group. The rats were followed for up to 80 weeks. FANFT administered at 0.2% in the diet for 11 weeks resulted in a high incidence of urinary tract tumors particularly of the renal pelvis. Similar results were obtained by administration of 0.2% FANFT for 6 weeks followed by 0.535% phenacetin while FANFT for 6 weeks preceded or followed by mechanical perforation of the renal pelvis resulted in a significantly lower incidence of renal pelvic tumors. Phenacetin appeared to enhance the development of renal pelvic tumors in FANFT-induced urinary tract carcinogenesis. In contrast no effect of phenacetin on the urinary bladder could be detected. | lld:pubmed |
| pubmed-article:6613585 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6613585 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6613585 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6613585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6613585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6613585 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6613585 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:6613585 | pubmed:issn | 0108-0164 | lld:pubmed |
| pubmed-article:6613585 | pubmed:author | pubmed-author:AnderströmCC | lld:pubmed |
| pubmed-article:6613585 | pubmed:author | pubmed-author:JohanssonS... | lld:pubmed |
| pubmed-article:6613585 | pubmed:author | pubmed-author:von SchultzLL | lld:pubmed |
| pubmed-article:6613585 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6613585 | pubmed:volume | 91 | lld:pubmed |
| pubmed-article:6613585 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6613585 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6613585 | pubmed:pagination | 373-80 | lld:pubmed |
| pubmed-article:6613585 | pubmed:dateRevised | 2009-6-4 | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:meshHeading | pubmed-meshheading:6613585-... | lld:pubmed |
| pubmed-article:6613585 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6613585 | pubmed:articleTitle | The influence of phenacetin or mechanical perforation on the development of renal pelvic and urinary bladder tumors in FANFT-induced urinary tract carcinogenesis. | lld:pubmed |
| pubmed-article:6613585 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6613585 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
